title: Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.
abstract: Recent studies have identified phosphoglucomutase 1 (PGM1) deficiency as an inherited metabolic disorder in humans. PGM1 deficiency is classified as both a muscle glycogenosis (type XIV) and a congenital disorder of glycosylation of types I and II. Affected patients show multiple disease phenotypes, reflecting the central role of the enzyme in glucose homeostasis, where it catalyzes the interconversion of glucose 1-phosphate and glucose 6-phosphate. The influence of PGM1 deficiency on protein glycosylation patterns is also widespread, affecting both biosynthesis and processing of glycans and their precursors. To date, 21 different mutations involved in PGM1 deficiency have been identified, including 13 missense mutations resulting in single amino acid changes. Growing clinical interest in PGM1 deficiency prompts a review of the molecular context of these mutations in the three-dimensional structure of the protein. Here the known crystal structure of PGM from rabbit (97 % sequence identity to human) is used to analyze the mutations associated with disease and find that many map to regions with clear significance to enzyme function. In particular, amino acids in and around the active site cleft are frequently involved, including regions responsible for catalysis, binding of the metal ion required for activity, and interactions with the phosphosugar substrate. Several of the known mutations, however, are distant from the active site and appear to manifest their effects indirectly. An understanding of how the different mutations that cause PGM1 deficiency affect enzyme structure and function is foundational to providing clinical prognosis and the development of effective treatment strategies.
authors.affiliation: Biochemistry Department, University of Missouri, 117 Schweitzer Hall, Columbia, MO, 65211, USA, beamerl@missouri.edu.
authors.forename: Lesa J
authors.initials: LJ
authors.lastname: Beamer
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D020134:Catalytic Domain; D020022:Genetic Predisposition to Disease; D006008:Glycogen Storage Disease / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics*; D006031:Glycosylation; D040941:Heredity; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D010641:Phenotype; D010733:Phosphoglucomutase / Q000737:chemistry / Q000172:deficiency / Q000235:genetics*; D011487:Protein Conformation; D011499:Protein Processing, Post-Translational; D011817:Rabbits; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
chemical_list: C488050:PGM1 protein, human; D010733:Phosphoglucomutase